IAMOG
AVXL icon

Investors Asset Management of Georgia’s Anavex Life Sciences AVXL Stock Holding History

Investors Asset Management of Georgia’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$1K – 205
2022
Q3 		$1K Hold
100
– – ﹤0.01% 591
2022
Q2 		$1K Buy
+100
New +$947 ﹤0.01% 546

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Investors Asset Management of Georgia's AVXL Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of Anavex Life Sciences (AVXL) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Investors Asset Management of Georgia first reported a position in AVXL in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 139 funds tracked by Wall St. Rank hold AVXL as of Q4 2022.

  • Investors Asset Management of Georgia reported no remaining Anavex Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Investors Asset Management of Georgia sold 100 Anavex Life Sciences shares in Q4 2022, an estimated $1K.
  • Investors Asset Management of Georgia first reported a position in Anavex Life Sciences in Q2 2022 and held it in 2 quarters.
  • Investors Asset Management of Georgia's Anavex Life Sciences position peaked at $1K in Q3 2022.
  • 139 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.